Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Drug Eluting Stent Registry of Thrombosis (DESERT)

This study has been completed.
Information provided by (Responsible Party):
Medstar Health Research Institute Identifier:
First received: December 18, 2008
Last updated: April 22, 2013
Last verified: April 2013
Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Drug Eluting Stent Registry of Thrombosis

Resource links provided by NLM:

Further study details as provided by Medstar Health Research Institute:

Primary Outcome Measures:
  • To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis [ Time Frame: Baseline ]

Enrollment: 984
Study Start Date: September 2009
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Late or very late drug-eluting stent thrombosis
No drug-eluting stent thrombosis


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).

Inclusion Criteria:

  • Patients over 18 years of age
  • Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
  • Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion Criteria:

  • Patients not meeting the above Inclusion Criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00812552

  Hide Study Locations
United States, California
Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research
Sacramento, California, United States, 95819
United States, District of Columbia
Washington Hospital Center
Washington, District of Columbia, United States, 20010
United States, Illinois
Prairie Education and Research Cooperative
Springfield, Illinois, United States, 62701
United States, Kentucky
Lexington Cardiac Research Foundation/Central Baptist Hospital
Lexington, Kentucky, United States, 40503
United States, Maine
Maine Medical Center
Portland, Maine, United States, 04102
United States, Maryland
Washington Adventist Hospital
Takoma Park, Maryland, United States, 20912
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Lahey Clinic
Burlington, Massachusetts, United States, 01805
United States, Missouri
Saint Luke's Hospital, Mid America Heart Institute
Kansas City, Missouri, United States, 64111
United States, New Jersey
The Valley Hospital
Ridgewood, New Jersey, United States, 07450
United States, New York
New York Methodist Hospital
Brooklyn, New York, United States, 11215
Columbia University Medical Center
New York, New York, United States, 10032
United States, North Carolina
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157
United States, Ohio
Summa Health System
Akron, Ohio, United States, 44309
United States, Pennsylvania
Geisinger Health System
Danville, Pennsylvania, United States, 17822
United States, Rhode Island
The Miriam Hospital
Providence, Rhode Island, United States, 02906
United States, South Carolina
South Carolina Heart Center, PA
Columbia, South Carolina, United States, 29204
United States, Virginia
Winchester Medical Center
Winchester, Virginia, United States, 22601
Canada, Quebec
Laval Hospital
Quebec City, Quebec, Canada, G1V4G5
Bern University Hospital
Bern, Switzerland, 3010
Sponsors and Collaborators
Medstar Health Research Institute
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Medstar Health Research Institute Identifier: NCT00812552     History of Changes
Other Study ID Numbers: DESERT
Study First Received: December 18, 2008
Last Updated: April 22, 2013

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases
Embolism and Thrombosis processed this record on May 25, 2017